Evidence map›Paper›PMID 26925499›Full record

ReviewAnnual review of pathology2016

Pathogenesis of Staphylococcus aureus Bloodstream Infections.

Lena Thomer, Olaf Schneewind, Dominique Missiakas

Open access · greenAbstract readReview
In one paragraph

Review in Annual review of pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 160 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
160citing papers in PubMed, 3 pooled it
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

160 citing papers in PubMed, 3 syntheses or guidelines pooled it, 279 citations in OpenAlex.

  1. Pooled it
  2. Risk factors for methicillin-resistantThe Journal of international medical research · 2022
    Pooled it
  3. Pooled it
  4. Staphylococcus aureus-vascular endothelium interactions: Mechanisms and therapeutic opportunities.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  5. Article
  6. Article
  7. Osteomyelitis.Nature reviews. Disease primers · 2026
    Review
  8. Review
  9. Genomic Characterization and Virulence Determinants ofAntibiotics (Basel, Switzerland) · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Defects in anaplerotic metabolism sensitizeMicrobiology spectrum · 2025
    Article
  17. Article
  18. Article
  19. Raman Monitoring ofInternational journal of molecular sciences · 2025
    Article
  20. Article

100 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lena ThomerDepartment of Microbiology, University of Chicago, Chicago, Illinois 60637; email: oschnee@bsd.uchicago.edu.
Olaf SchneewindDepartment of Microbiology, University of Chicago, Chicago, Illinois 60637; email: oschnee@bsd.uchicago.edu.
Dominique MissiakasDepartment of Microbiology, University of Chicago, Chicago, Illinois 60637; email: oschnee@bsd.uchicago.edu.
University of Chicago · US

Funding

Surface Proteins of Gram-Positive BacteriaR01AI038897 · NIAID · UNIVERSITY OF CHICAGO · PI MISSIAKAS, DOMINIQUE M. · 1996 to 2024
$8.9M
Vaccine Assembly from Surface Proteins of Staphylococcus AureusR01AI052474 · NIAID · UNIVERSITY OF CHICAGO · PI Dominique Missiakas · 2002 to 2026
$8.8M
Molecular basis and intervention of Staphylococcus aureus agglutinationR01AI110937 · NIAID · UNIVERSITY OF CHICAGO · PI MISSIAKAS, DOMINIQUE M. · 2015 to 2019
$1.8M
Molecular basis and intervention of Staphylococcus aureus agglutinationR56AI110937 · NIAID · UNIVERSITY OF CHICAGO · PI MISSIAKAS, DOMINIQUE M. · 2014 to 2014
$389k
NIAID NIH HHS R01 AI038897NIAID NIH HHS R01 AI052474NIAID NIH HHS R01 AI110937NIAID NIH HHS R56 AI110937
6 · The paper itself

Abstract

Staphylococcus aureus, a Gram-positive bacterium colonizing nares, skin, and the gastrointestinal tract, frequently invades the skin, soft tissues, and bloodstreams of humans. Even with surgical and antibiotic therapy, bloodstream infections are associated with significant mortality. The secretion of coagulases, proteins that associate with and activate the host hemostatic factor prothrombin, and the bacterial surface display of agglutinins, proteins that bind polymerized fibrin, are key virulence strategies for the pathogenesis of S. aureus bloodstream infections, which culminate in the establishment of abscess lesions. Pathogen-controlled processes, involving a wide spectrum of secreted factors, are responsible for the recruitment and destruction of immune cells, transforming abscess lesions into purulent exudate, with which staphylococci disseminate to produce new infectious lesions or to infect new hosts. Research on S. aureus bloodstream infections is a frontier for the characterization of protective vaccine antigens and the development of immune therapeutics aiming to prevent disease or improve outcomes.

Indexed as

BacteremiaHumansStaphylococcal InfectionsStaphylococcus aureusVirulenceabscess formationagglutinationcoagulationimmune evasionvaccine

Identifiers

PMID26925499
PMCPMC5068359
OpenAlexW1716237860

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.